TrialThe Journal of clinical endocrinology and metabolism2025

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.

Bhavana Konda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.